Life
CAR-T Therapy Continues to Impress Autoimmunity Researchers Five Years After Lupus Breakthrough
Five years post-lupus breakthrough, CAR-T therapy shows promise in autoimmune disease remissions, sparking increased research and investment.
editorial-staff
1 min read
Updated 2 days ago
Summary
Five years after a significant breakthrough in lupus treatment, CAR-T therapy is demonstrating its potential in the realm of autoimmune diseases.
This innovative therapy is reportedly leading to more remissions, which has caught the attention of researchers and investors alike.
As a result, there is a noticeable surge in experimentation and funding directed towards exploring CAR-T's applications in treating various autoimmune conditions.
Updates
- No subsequent updates recorded.